Monocyte recruitment and adherence are important events in inflammatory and vascular diseases. Here, we evaluated the actions of lipoxin A 4 (LXA4) and LXB4, a series of lipoxygenase products from arachidonic acid generated by cell-cell interactions, on human monocytes. LXA 4 and LXB 4 (10 -7 M) each increased monocyte migration in chamber chemotaxis assays and, in migration under agarose, exhibited chemotactic indices similar to those of the chemotactic peptide formyl-methionyMeucyl-phenylalanine at 10-1~ -8 M and to the chemokine macrophage inflammatory protein-lot (MIP-lot) at 10-s-10 -7 M with a rank order of potency: Monocyte chemotactic protein-lot ~LXA 4 ~ LXB 4 ~ MIP-lot. Lipoxins also stimulated monocyte adherence to laminin. In addition, human monocytes rapidly transformed ERA 4 and LXB 4 to several metabolites. LXB 4 (>80%) was converted within 30 s to new products, in a trend similar to that of LXA 4. The novel monocyte-derived LXB 4 products were identified as 5-oxo-6,7-dihydro-LXB 4 and 6,7-dihydro-LXB4, indicating a role for site-selective dehydrogenation and reduction. Unlike monocytes, intact polymorphonuclear leukocytes (PMN) did not metabolize LXA 4 in significant quantities, and only r of exogenous LXB 4 was c0-oxidized to 20-OH-LXB 4 and 20-COOH-LXB 4 by PMN. To determine if lipoxin conversion altered bioactivity, we evaluated the actions of these metabolites on monocytes. Each of the novel products of LXA 4 and LaB 4 from monocytes, namely oxo-and dihydrolipoxins, were essentially inactive in stimulating monocyte adherence. In contrast, the m-oxidation products of LXB 4 isolated from PMN were equipotent with LXB 4 for monocyte adherence. Dehydrogenation of ERA 4 in monocytes appears to be carried out by a 15-hydroxyprostaglandin dehydrogenase, which is present in human monocytes as determined by reverse transcription PCR and Western blots. Together, these results provide the first evidence that ERA 4 and LXB 4 are both potent stimulants for migration and adherence of human monocytes. Moreover, they underscore the importance of the major route of lipoxin metabolism in leukocytes, namely, the rapid dehydrogenation and inactivation carried out by monocytes.
A ctivation of peripheral blood leukocytes, leading to adherence to damaged vessel walls and extravasation into surrounding tissue, is an important event in many inflammatory and vascular diseases (1, 2) . Leukotriene B 4 CLTB4) 1, a 1Abbreviations used in this paper: BCECF-AM, [2'-7 '-bis-(carboxyethyl)-5(6')-carboxyfluorescein acetoxymethyl]-ester; CR, carbonyl reductase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HETE, hydroxyeicosatetraenoic acid; LTB4, leukotriene B4; LXA4, lipoxin A4; LXB4, lipoxin B4; MCP-1, monocyte Chemotactic protein-I; MIP-let, macrophage inflammatory protein-la; NAD +, nicotinamide adenine dinucleotide; NADP, nicotinamide adenine dinucleotide phosphate; 15-PGDH, 15-hydroxyprostaglandin dehydrogenase; RP-HLPC, reverse phase HPLC; RT, reverse transcription. lipoxygenase product of arachidonic acid, is a potent activator of PMN chemotaxis and adherence (3) . Another class of lipoxygenase products from cell-cell interactions, the lipoxins, display selective activities on human leukocytes that have been shown to be both stimulatory and inhibitory, depending on the cell type involved. In human PMN, lipoxin A 4 (LXA4) (10-9-10 .7 M) induces chemokinesis but inhibits chemotaxis toward LTB 4 and FMLP (4) . LXA 4 (10 -8 M) also inhibits FMLP-stimulated PMN transmigration across intestinal epithelium (5) . In human eosinophils, tXA 4 also inhibits chemotaxis toward both FMLP and platelet activating factor (6) . Lipoxin B 4 (LXB4) (nanomolar range) is reported to stimulate colony formation and differ-entiation toward macrophage lineage in mononuclear leukocyte populations (7) . These findings indicate that LXA 4 and LXB 4 each display selective actions on human leukocyte subtypes.
The major routes of further metabolism, which regulate eicosanoid bioactivity in human tissues, include ~-oxidation, t0-oxidation, and dehydrogenation (for review see reference 8) . Our laboratory has demonstrated that human peripheral blood monocytes transform LXA 4 to 15-oxo-LXA 4, 13,14-dihydro-15-oxo-LXA 4, and 13,14-dihydro-LXA 4 (9) , which suggested that lipoxins, or their metabolites, may have bioactions in monocytes and that the transformation may alter lipoxin bioactivity to enhance or decrease their potency. The present results document previously unrecognized bioactivities of both LXA 4 and LXB 4 in human monocytes and establish the importance of lipoxin further metabolism in these cells.
Materials and Methods
Cell Isolation. Human monocytes were isolated using a modification of the method of Denholm and Wolber (10) . Briefly, whole blood collected in acid citrate dextrose from healthy volunteers was centrifuged (200 g) at 25~ for 15 min for removal of platelet-rich plasma. The cells were then layered over FicollHypaque (LSM; Organon Teknika, Durham, NC) and centrifuged (500 g) at 25~ for 35 min. The mononuclear cell layer was collected, washed once, and resuspended in PBS 2-containing 0.l% BSA. 8 nil ofa Percoll: 10X HBSS (10: 1.65) mixture was added to 4 ml mononuclear cells in 10 X 1.5-cm round-bottom silanized polypropylene tubes and centrifuged (370 g) at 25~ for 30 min. Monocytes were collected from the upper 5 mm of the gradient and washed before counting and viability assessment. Human PMN were isolated by the B6yum method (11) from peripheral blood obtained from healthy volunteers. Cells were identified by Wright-Giemsa staining. The monocyte population was >90% with <10% contaminating lymphocytes, and PMN were >95% pure. Both monocytes and PMN contained platelets at approximately a 2:1 ratio ofplatelets to leukocytes. Viability of cells in all reported experiments was >95% as determined by their ability to exclude trypan blue.
Chemotaxis. Chamber chemotaxis was evaluated using a microchamber technique according to the method of Falk et al. (12) . Briefly, monocytes were isolated as above and resuspended at 5 X 106/mi in PBS 2+. Chemoattractant solution or vehicle (PBS 2+ containing 0.05% ethanol) was added to the lower wells of a 48-well chemotaxis chamber (Neuro Probe, Cabin John, MD). A polycarbonate membrane with 5-lxm diameter pores (Poretics Corp., Livermore, CA) was layered on top of the chemoattractant wells, and monocytes were added to the top wells. After incubation for 90 min at 37~ the membrane was removed, scraped of cells from the upper surface, and stained with modified Wright-Giemsa stain. Cells that had migrated through the membrane in four high-power fields were counted.
Chemotaxis under agarose was performed using conditions from the methods ofA1-Sumidaie et al. (13) . Briefly, agarose migration plates were prepared using 0.75% agarose (Type IV; Sigma Chemical Co., St. Louis, MO) dissolved in HBSS 2+ (pH 7.0) with 10% human serum, which was added to 60-mm diameter tissue culture dishes. Chemotactic agents and HBSS 2+ (10 p,1) were added to each of the inner and outer wells, respectively, and the plates were incubated at 37~ in humidified air with 5% CO 2 for 45 rain. Fluid was aspirated from all wells and replaced with fresh chemoattractant or HBSS 2+, and cells (106 in 10 Ixl) were added to the middle wells of each set. The plates were then incubated at 37~ in humidified air with 5% CO2 for 18-20 h, after which the cells were fixed with glutaraldehyde and stained with modified Wright-Giemsa stain. Cell migration was quantitated by measuring the linear distance the cells had moved from the margin of the wells toward the chemoattractant (D, directed migration) and away from it (C, random migration) as well as toward (A) and away (/3) from vehicle control wells. Laminin Adhesion. Isolated monocytes were suspended in PBS 2-(4 X 106/m]) and [2'-7 
'-bis-(carboxyethyl)-5(6')-carboxy-
fluorescein acetoxymethyl]-ester (BCECF-AM; Calbiochem Corp., La Jolla, CA) was added (1.0 IzM) and incubated with cells for 20 min at 37~ Cells were washed and resuspended (3.3 • 106/ml) in PBS 2+ containing 0.1% BSA. 90-1*1 aliquots of cells were added to each well of a 96-well flat-bottom tissue culture plate coated with laminin (Collaborative Biomedical Products, Bedford, MA) and allowed to settle for 10 min. 10 Ixl of agonist or vehicle was added to each well, and plates were incubated at 37~ for 20 min. After incubation, wells were aspirated and washed once with PBS 2+ containing 0.1% BSA. Cells adhering to the wells were solubilized with 0.025 M NaOH containing 0.1% SDS (100 Ixl), followed by fluorescence quantitation on a plate fluorimeter.
Products of Lipoxin Metabolism: Isolation and Identification.
For generation and isolation of the oxo-and dihydro-metabolites of lipoxins, monocytes were resuspended at 125 X 10 6 cells/5 ml PBS 2+ and incubated with 500 ng LXA 4 and 100,000 dpm [11, 12- 3H]LXA4, as in Serhan et al. (9) , or 1.0 Ixg LX-B4 at 37~ ~0-Oxidation products of LXA 4 and LXB 4 were obtained from PMN resuspended at 150 X 106 cells/3 ml PBS 2+ and incubated with 2.0 Ixg LXA4 or LXB 4 at 37~ Incubations were stopped at 0.5, 1, 5, and/or 20 min with cold methanol containing PGB2 as an internal standard. Products were extracted and chromatographed as described in Serhan et al. (9) . To obtain quantities of compounds sufficient for structural identification and biological assays, multiple incubations (n = 4) were extracted, stored at -20~ and pooled before reverse phase (1KP)-HPLC separation. The HPLC system consisted of a gradient dual pump (LKB-Pharmacia, Piscataway, NJ) equipped with an Altex Ultrasphere-ODS (4.6 mm X 25 cm) column (Alltech Assoc. Inc., Deerfield, IL), flow rate 1 ml/min, eluted (T0-20 rain) with methanol/HzO/ acetic acid (65:35:0.01, vol/vol/vol) and methanol~acetic acid (99.99:0.01, vol/vol) in a linear gradient (20-45 min) that was used to quantitate and recover lipoxin-derived metabolites. Online spectra were recorded using a diode array detector (1040M series II; Hewlett-Packard Co., Palo Alto, CA) equipped with HPLC 3D ChemStation software (Hewlett-Packard Co.). Gas chromatography/mass spectroscopy was performed as in Serhan et al. (9) using a mass selective detector quadrupole (model 5971A; Hewlett-Packard Co.) and gas chromatograph (model 5890; Hewlett-Packard Co.) using a HP-Ultra 2 column (crosslinked 5% phenyl methyl silicone gum phase; 25 cm X 0.2 mm • 0.33 ~m). Before analysis, products were treated with diazomethane and converted to their trimethylsilyl derivatives using bis(trimethylsilyl) trifluoroacetamide.
Monocyte-derived LXA 4 metabolites 15-oxo-LXA 4, 13,14-dihydro-15-oxo-LXA4, and 13,14-dihydro-LXA 4 were isolated and identified as in Serhan et al. (9) and gave physical criteria consistant with reported data. The monocyte-derived LXB 4 products were identified using the criteria of Ho and Wong (15) for 6,7-dihydro-LXB 4 that was identified from potatoes. This product had an HPLC retention time of 2.5 min and showed a UV spectrum with triplet maxima at 258, 268, and 279 nm (+4 rim, recorded on line). The mass spectrum of the Me3Si deriva- PMN-derived products of LXB 4 were identified as in Mizukami et al. (16, 17) . Briefly, the UV chromophores of the (0-oxidation products, 20-OH-LXB 4 and 20-COOH-LXB 4, were essentially identical to LXB4, showing UV )tm~ x at 287, 301, and 315 nm (+_4 nm). The tLP-HPLC retention time of 20-OH-LXB 4 was 3.6 min, and the mass spectrum of the Me3Si methyl ester derivative was characterized by major ions as reported in Mizukami et al. (16) . 20-COOH-LXB 4 eluted from this HPLC system at 2.9 min and its Me3Si methyl ester derivative showed major ions in its mass spectrum in agreement with those recently reported by Mizukami (17) , namely m/z 203 (base peak), 217,
(M+-217), 423 (M+-203), and 626 (M+).
Reverse Transcriptase PCR. Total tLNA was isolated from monocytes using differential extraction of tLNA with phenol at an acidic pH (18) , and preparations with a RNA/protein ratio >2 were used for poly(A) + tLNA selection. Poly(A) + tLNA was selected by affinity chromatography on oligo(dT)-cellulose (18) . Poly(A) + 1KNA (1 b~g) from monocytes was reverse transcribed to cDNA in 20 btl total volume using avian leukemia virus reverse transcriptase (RT), RNAsin | (10 U), MgC12 (5 raM), oligo(dT) primer (0.5 I.Lg), dNTPs (1 mM), and buffer with a 1KT kit (Promega Corp., Madison, WI) and incubated for 1 h at 42~ The reaction was stopped by heating to 100~ for 10 rain, immediately followed by storage on ice. Specific primers were designed for 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and carbonyl reductase (elK) using Sequence Analysis Software Package (Genetics Computer Group, University of Wisconsin, Madison, WI) and published sequences of the two genes (19, 20) . The primers used for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were as published in Hla and Maciag (21) . PC1K amplifications were performed using cDNA (5 b~l) with either 15-PGDH-, GAPDH-, or CR-specific primers (Integrated DNA Technologies, Inc., Coralville, IA). The sequences of the sense and antisense primers for PGDH were: PGDH sense, 5'-CAC GTG AAC GGC AAA GTG-3'; PGDH antisense, 5'-GCA TTA TTG ACC AAA ATG TCC A-3'. The sequences for the GAPDH primers, which were used as a control, were: GAPDH sense, 5'-CCA CCG ATG GCA AAT TCC ATG GCA-Y; and GAPDH antisense, 5'-TCT AGA CGG CAG GTC AGG TCC ACC-3'. CR primers were: CR sense, 5'-CCT GAG CCA GGT CTG TTC TC-3'; and C1K antisense, 5'-GGG TGT GGG ATC AGC AAC-Y. Sequence amplification was performed in a total volume of 25 bd, using 0.5 I~M each of sense and antisense primers, dNTPs (0.2 raM), MgCI 2 (1.5 raM), Taq polymerase (1.5 U) (Promega Corp.) and 10X buffer (2.5 btl) included with the enzyme. The reactions were amplified by 35 repetitive cycles of denaturation at 94~ for 30 s, annealing at 55~ for 1 rain, and extension at 72~ for 2 min. Amplified DNA was electrophoresed in 2% agarose gels containing ethidium bromide, and bands were photographed.
SDS-PAGE and Immunoblotting. Monocytes were suspended
in PBS 2-(50 X 106 cells/m]) and sonicated in an ice bath for three bursts of 30 s each (Branson Sonifier 250; Branson Sonic Power Co., Danbury, CT). The 100,000 g supernatant was used in SDS-PAGE and immunoblots for 15-PGDH. Human placenta (1 g) was cut into pieces ,'~1 mm 3, 3 ml PBS 2-was added to the tissue, and 1.5-ml aliquots were homogenized 4 5< 2 rain at 0~ at the highest setting of a tissue homogenizer (Talboys Instrument Corp., Montrose, PA). Supernatants used for SDS-PAGE and immunoblotting were prepared by centrifuging the homogenate at 10,000g for 20 rain at 4~
Proteins were fractionated by SDS-PAGE according to the method of Laemm]i (22) . Electrophoretic transfer of proteins was performed as in Towbin et al. (23) , except polyvinylidine difluoride (DuPont-NEN, Boston, MA) was used as the transfer membrane. 15-PGDH was visualized using rabbit anti-PGDH antiserum as 1 ~ antibody (a generous gift from Dr. H.-H. Tai, University of Kentucky, Lexington, KY) and a 2 ~ peroxidaseconjugated goat anti-rabbit IgG (Sigma Chemical Co.), followed by treatment with chemiluminescent reagents (DuPont-NEN) and exposure on radiographic film (R.X; Fuji Photo Film Co., Elmsford, NY).
Statistical Analysis. Data were analyzed using paired or unpaired Student's t tests, and significance was determined at p < 0.05.
Results
Chemotaxis. LXA 4 and LXB 4 both proved to be potent chemoattractants for monocytes (Fig. 1) . In chamber chemotaxis assays with monocytes, FMLP is maximally active at concentrations of 10-8-10 -7 M (24) and in the present experiments, it increased migration by 4. Chemotaxis was quantitated in chambers using agonists at equimolar concentrations (10 -7 M). Values represent mean numbers (+ SE) of monocytes that migrated through 5-1xm polycarbonate filters in four standard high-power fields after incubation for 90 min at 37~ for three separate experiments performed in triplicate. *Denotes values significantly higher than vehicle (p <0.05).
gave statistically significant monocyte chemotaxis at 10 -7 M that was approximately three times greater than vehicle controls. Next, migration under agarose was used to examine concentration dependence of the lipoxin response and distinguish chemotaxis from chemokinesis. The use of migration under agarose allowed assessment of directed versus spontaneous migration and also required fewer cells than the chamber system, which permitted direct comparison of concentration dependency for both LXA 4 and LXB 4 with cells from the same donor. The chemotactic response to LXA 4 and LXB 4 was concentration dependent from 10 -1~ 10 -6 M (Fig. 2) . The chemotactic indices (as defined in Colgan et al. [14] ) for LXA 4 and LXB 4 were comparable to that of FMLP from 10-1~ -8 M. Only at 10 -7 M was the chemotactic index of FMLP greater than LXA 4 and LXB4, and at 10 -6 M FMLP, this index dropped precipitously, whereas with ERA 4 and LXB4, chemotactic response continued to increase. Monocyte migration for LXA 4 was also directly compared with human recombinant chemokines, monocyte chemotactic protein (MCP-1) and macrophage inflammatory protein (MIP-lo 0 (R&D Systems, Inc., Minneapolis, MN) ( Table 1 ). The relative potency of LXA 4 was equal to MIP-lcx and was ~1 log less than MCP-1. These data reveal that LXA 4 and LXB 4 are potent activators of monocyte migration at submicromolar concentrations, comparable to equimolar concentrations of the chemotactic peptide, FMLP, and the monocyte chemokines.
Adherence. Since chemotaxis is one of the steps involved in diapedesis of leukocytes from blood vessels into tissue, it was also of interest to examine the ability of Ii- unrecognized bioactions of LXA 4 and LXB4, we next established a time course of monocyte adhesion, as well as concentration dependence for both LXA 4 and LXB 4. The stimulator,/action of the lipoxins proved to be concentration dependent (Fig. 4) , with the highest activity tested at 10 -6 M for both compounds. Minimal monocyte adhesion activity was observed at 10 -~~ M for both LXA 4 or LXB 4. The time course of lipoxin-stimulated monocyte adhesion showed a rapid increase that was apparent within the first 5 min and plateaued between 10 and 20 min (Fig. 4, inset) .
This is similar to the time course previously demonstrated for both LTB 4 and FMLP induced monocyte adherence (24) . These results establish that LXA 4 and LXB 4 can rapidly and significantly stimulate monocyte adherence to laminin which, at 10 -7 M, is not significantly different from that induced by FMLP, and is greater than the LTB 4 response (p <0.05). lized, and in incubations with LXB 4 and intact PMN, <15% conversion of the native LXB 4 was observed (Fig. 5) . Next, for evaluation of their biological significance, each of the lipoxin-derived products from human leukocytes was isolated as described in Materials and Methods. The LXA4-derived compounds included 15-oxo-LXA4, 13,14-dihydro-15-oxo-LXA4, and 13,14-dihydro-LXA4, as reported in Serhan et al. (9) . Products of LXB 4 from both monocytes and PMN were separated by P,.P-HPLC and collected for gas chromatography/mass spectroscopy analysis and bioassay (see Materials and Methods). LXBa-derived metabolites isolated and identified from monocyte incubations were 5-oxo-6,7-dihydro-LXB 4 and 6,7-dihydro-LXB 4. We were not able to isolate a sufficient quantity of putative 5-oxo-LXB 4 from intact monocytes for physical analysis and bioassays because of its apparent chemical instability. Together, these results indicate that monocytes rapidly convert both LXA 4 and LXB 4 ( (Fig. 6) . When PMN were exposed to FMLP (10 -7 M) at the time ofLXB 4 addition, conversion to co-oxidation products increased to ~50% of added LXB 4 (r/ = 2). In contrast, addition of the Ca 2+ ionophore A23187 (2.5 btM) completely inhibited transformation ofLXB 4 by PMN (n = 3), presumably due to competition for co-oxidation at the enzyme level with endogenously generated LTB 4, indicating that LTB 4 is the preferred substrate in PMN. This interpretation is consistent with the K~ values reported by Mizukami et al. (16) . Thus, the major route to lipoxin 5-OXO-6, 7-6,7~i hydro-20-COOH-20-OHdi hydro-LXB 4 LXB, LXB 4 LXB 4 LX2B4) did n o t carry biologic activity (Fig. 7 B) . In contrast, the m-oxidation products isolated from P M N ( 2 0 -O H -LXB 4 and 2 0 -C O O H -L X B 4 ) were similar to the activity of native LX]34 in stimulating m o n o c y t e adherence to laminin (Fig. 7 B) . Together, these results indicate that E R A 4 and LXB 4 are inactivated by monocytes. Mso, the finding that the to-oxidation products were essentially equipotent with LXB 4 indicates that the m o n o c y t e response is stereoselective. (9), which display 1 5 -P G D H activity (27) . Based on the presence of an alcohol at carbon 15 in both lipoxins and prostaglandins, we considered 1 5 -P G D H or carbonyl reductase (a nicotinamide adenine dinucleotide phosphate ( N A D P + ) -d e p e ndent P G dehydrogenase) as candidates involved in the conversion oflipoxins by monocytes. T o test this, we evaluated the presence of these enzymes in monocytes via R T -P C R and protein i m m u n o b l o t t i n g techniques. T h e results o f R T -P C R showed a distinct band using the 1 5 -P G D H primers, indicating that 1 5 -P G D H R N A is present in monocytes, as was the control enzyme, G A P D H (Fig. 8  A) . Carbonyl reductase primers produced less consistent re- sults, with no cDNA product visible from some donors (as shown in Fig. 8 A) , or a very faint band from other donors. Because 15-PGDH primers resulted in consistent, distinct bands via 1KT-PC1K, we examined the presence of the 15-PGDH protein in monocyte cytosol by Western blot. A protein immunoblot, using human placenta as positive control, shows a faint band at 29 kD from monocyte cytosol (Fig. 8 B) . In addition, stronger bands were visible at ,'~ kD (also seen in the placenta), which have been previously documented in 15-PGDH immunoblots and are attributed to incomplete dissociation of the protein into subunits (27) . Taken together, the 1KT-PC1K and immunoblot demonstrate the presence of both 15-PGDH mlKNA and imrnunoreactive enzyme in human monocytes.
Transformation of Lipoxins by

Discussion
Results obtained in these studies demonstrate for the first time that both LXA 4 and LXB 4 are potent agonists for human monocyte migration and adhesion. LXA 4 and LXB4, at submicromolar concentrations, stimulate migration of monocytes in a dose range similar to the chemoattractant peptide FMLP and the monocyte chemokines MCP-1 and MIP-10t (Figs. 1 and 2, Table 1 ). Both LXA 4 and LXB 4 also stimulate adherence of monocytes to laminin-coated plastic in a concentration-dependent manner and were equipotent with FMLP and LTB 4 (Figs. 3 and 4) . Both LXA 4 and LXB 4 were subject to rapid further metabolism by human monocytes and were only minimally transformed by intact PMN (Fig. 5) . Direct comparison of both LXA 4-and LXB4-derived monocyte products in monocyte adherence revealed that the novel products of both lipoxins did not carry biologic activity (Fig. 7) . These results are in sharp contrast to those observed with the quantitatively minor c0-oxidation products of LXB 4 isolated from PMN, namely, 20-OH-LXB 4 and 20-COOH-LXB4, which were equipotent with the parent molecule ( Fig. 7/3 ).
Activation ofmonocyte migration and adherence is relevant to numerous inflammatory and vascular diseases, including vital initiating events in atherosclerosis (1, 2) . These are also the first steps in normal differentiation and maturation of circulating monocytes to tissue macrophages (1) . Because our results show that LXA 4 and LXB 4 stimulate both chemotaxis and adherence of monocytes, it follows that lipoxins may play a role in physiologic monocyte trafficking and/or pathologic processes in which monocytes are involved. This is underscored by the finding that monocytes inactivate both LXA 4 and LXB 4 (Fig. 8) .
It is of interest to point out that lipoxins activate human monocytes and inhibit human PMN activity stimulated by other agonists. LXA 4 inhibits FMLP-stimulated transmigration of PMN through epithelium (5) and FMLP-or LTB 4-induced PMN chemotaxis (4). In addition, LXA 4 and LXB 4 inhibit LTB 4-and LTC4-stimulated adherence of PMN to endothelium (28) and LTDg-stimulated PMN adherence to mesangial cells (29) . The differential action oflipoxins with PMN versus monocytes is intriguing, Monocytes and PMN can respond in opposing manners to the same stimulus; for example, phorbol ester stimulates PMN adhesion but inhibits monocyte adhesion to endothelial cells (30) . Therefore, it is possible that lipoxins are acting via some shared intracellular second messengers in both monocytes and PMN, but are eliciting antithetical responses from the cells. Recently, we identified a previously denoted orphan seven-transmembrane receptor as a highaffinity receptor for LXA 4 present in PMN and differentiated HL-60 cells that has 67% sequence homology with the FMLP receptor (31) . The presence of this receptor mlKNA has also been identified in human monocytes (32) . These results, together with those presented here, suggest that LXA 4 is likely acting via the same receptor in monocytes and PMN. Mobilization of intracellular Ca 2+ by lipoxins was also examined, and we found that, at submicromolar concentrations, LXA 4 stimulates increases in intracellular Ca 2+ (monitored by Fura-2) in both monocytes and THP-1 cells, but in parallel experiments LXB 4 did not induce a signal of comparable magnitude (Romano, M., and C. Serhan, manuscript in preparation). This suggests that the postreceptor interactions in each cell type may be distinct. Along these lines, LXB 4 does not bind to the same receptor as LXA 4 (31) , and likely has a unique receptor or site of action in monocytes.
In general, eicosanoids can be rapidly transformed to increase or decrease their activity in target tissues (33) (34) (35) . LXA 4 is metabolized in monocytes by dehydrogenation and reduction (Fig. 6) , and the proposed sequence of transformation is LXA4-->15-oxo-LXA4-+13,14-dihydro-15-oxo-LXA4-+13,14-dihydro-LXA 4 (9) . Based on results presented here (see Materials and Methods), it is likely that LXB 4 is transformed via a similar pathway (Fig. 8) . Therefore, the hypothetical scheme for LXB 4 metabolism in monocytes can proceed as follows: LXB4--+5-oxo-LXB4--> 5 -oxo-6,7-dihydro-LXB4---)6,7-dlhydro-LXB 4 .
An increase or decrease in the bioactivity of individual eicosanoid further metabolites can be cell type and/or tissue specific. The LTB 4 metabolites 20-OH-LTB 4 and 20-COOH-LTB4, for example, are known to be markedly less potent chemoattractants for PMN than LTB 4 (33), and dehydrogenation of prostanoids is generally thought to be an inactivation step (for reviews see references 8 and 35). In contrast, the recently identified 5-oxo-HETE, a dehydrogenase product of 5-HETE isolated from PMN, has been shown to possess potent stimulatory properties for PMN (34) . LXA 4 and LXB 4 m-oxidation products were isolated from microsomes from human PMN (16, 36, 37) and rat liver cells (17) , but no evaluation of biological activity of these metabolites was presented. These are likely the lipoxin products of the P450 enzyme, which acts on LTB 4 as a preferred substrate (16) . These results are the first to compare bioactivities of the novel monocyte lipoxin-derived metabolites and the c0-oxidation products of lipoxins with the parent compounds. The results clearly show that conversion of LXA 4 and LXB 4 in monocytes by dehydrogenation and reduction of double bonds results in inactivation. In contrast, co-oxidation of LXB 4 to 20-OH-LXB 4 and 20-COOH-LXB 4 causes no apparent change in potency in stimulating monocyte adhesion to laminin. These results give clues to the key structural elements of the lipoxin molecules involved in recognition and activation of monocytes; namely, changes at the m end (carbon 20) appear to have no effect, but alteration of the hydroxyl groups at C5 in LaB 4 or C15 in LXA4, or reduction of the adjacent double bond (Fig. 8) , results in a loss of activity. These results suggest that the segments of the molecules containing the tetraene structures are key in defining bioactivity in the monocyte.
Several key enzymes have been identified that are involved in the metabolism of eicosanoids via each of the main pathways, including B-oxidation, t0-oxidation, dehydrogenation, and/or reduction. LTB4, for example, is converted by m-oxidation in PMN by a cytochrome P450 enzyme (38) . Dehydrogenases are important enzymes catalyzing the transformation of PGE 2 to its major metabolite, 15-keto-PGE 2, in many different tissues (35) and in converting 5-HETE to 5-oxo-HETE in human PMN (39) . NAD+-dependent 15-PGDH is one enzyme responsible for this further metabolism of prostanoids and has been cloned from human placental tissue (19) . An NADP+-dependent prostaglandin dehydrogenase activity is also present in placental tissue, attributed to the somewhat nonspecific activity of carbonyl reductase, which has also been cloned (20) . Both lipoxins carry C15 alcohol groups (Fig. 6) , and in PMA-differentiated HL-60 cells, which express 15-PGDH (27) , LXA 4 blocked ,'~ of 15-HETE conversion to 15-oxo-HETE at equimolar concentrations (9) . Therefore, we hypothesized that one or both of these dehydrogenase enzymes could catalyze the formation of oxolipoxins. Results showed distinct presence of 15-PGDH mRNA in monocytes (Fig. 8 A, lane 3) . Western blots also established that 15-PGDH protein is transcribed in monocytes and, therefore, is likely to contribute to the metabolism of LXA 4 by monocytes. This finding does not preclude the presence of additional, and/or potentially novel, enzymes that can carry out similar transformations. The C5 alcohol group ofLXB 4 is less likely to be susceptible to 15-PDGH activity and, though it is possible that the unique dehydrogenase that converts 5-HETE to 5-oxo-HETE is responsible (39) , there is a lack of extensive conversion of LX_B 4 to 5-oxo-LXB 4 by intact PMN (Figs. 5 and 6 ), where this eicosanoid dehydrogenase activity was observed.
The results of this report are the first to describe potent actions for LXA 4 and LXB 4 on human monocyte migration and adherence, and rapid metabolic transformation by monocytes to novel products that do not carry these activities. Monocytes routinely migrate into normal tissue for differentiation into resident macrophages, whereas PMN generally extravasate in response to injury or infection, and in these scenarios, PMN are immediately responsive, whereas monocytes migrate in at a later stage. These distinctive behavior patterns of monocytes versus PMN suggest that these cell types respond uniquely to the same stimuli. This difference in temporal response would be an ideal setting for the production of lipoxins by PMN interacting with platelets and endothelium at sites of inflammatory or vascular injury. This early response phase (40) (41) (42) could lead to recruitment of monocytes to the same site, but at a later time point. Thus, our results suggest that lipoxins generated by PMN-platelet interactions in vascular and/or inflammatory diseases could recruit monocytes, which then are able to self-limit the reaction by rapid further metabolism and downregulation of LXA 4 and LXB 4 bioactivity.
